期刊目次

加入编委

期刊订阅

添加您的邮件地址以接收即将发行期刊数据:

Open Access Article

International Research in Chinese Medicine. 2022; 2: (1) ; 18-20 ; DOI: 10.12208/j.ircm.20220005.

Clinical observation of combined Chinese and Western medicine in the treatment of coronary heart disease and angina pectoris
中西药联合治疗冠心病心绞痛临床观察

作者: 潘吉猛 *, 吕沛霖

四平市铁西区人民医院 吉林四平

凤城市中医院介入医学科 辽宁凤城

*通讯作者: 潘吉猛,单位:四平市铁西区人民医院 吉林四平;

发布时间: 2022-05-19 总浏览量: 497

摘要

目的 研究中西药联合治疗冠心病心绞痛效果。方法 选择2020年01月-2021年12月到本院治疗冠心病心绞痛的患者104例,依照治疗方式的不同,分成实验组和对照组,分析治疗效果。结果 治疗后,实验组患者心功能指标优于对照组,P<0.05;实验组患者血脂水平、6分钟步行距离优于对照组,P<0.05;治疗前,组间IMT、斑块面积指标对比,P>0.05,治疗后,组间IMT、斑块面积指标对比,P<0.05。结论 运用中西药联合方式对冠心病心绞痛治疗,效果确切,值得推广。

关键词: 中西药联合;冠心病心绞痛;临床疗效

Abstract

Objective: To study the effect of Chinese and Western Medicine on angina pectoris of coronary heart disease.
Methods: 104 patients with coronary heart disease and angina pectoris treated in our hospital from January 2020 to December 2021 were divided into experimental group and control group according to different treatment methods, and the treatment effect was analyzed.
Results: after treatment, the indexes of cardiac function in the experimental group were better than those in the control group (P < 0.05); The blood lipid level and 6-minute walking distance in the experimental group were better than those in the control group (P < 0.05); Before treatment, the indexes of IMT and plaque area between groups were compared, P > 0.05. After treatment, the indexes of IMT and plaque area between groups were compared, P < 0.05.
Conclusion  : the combination of Chinese and Western medicine is effective in the treatment of angina pectoris.

Key words: Combination of Chinese and Western Medicine; Coronary Heart Disease, Angina Pectoris; Clinical Efficacy

参考文献 References

[1] 肖宝勤. 以循证理念为基础行中西医结合护理对老年冠心病心绞痛的影响[J]. 实用中医内科杂志,2021, 35(7): 85-87.

[2] 吴一凡,王舒舒,叶小嬉嬉. 益气活血逐瘀方治疗气虚血瘀型冠心病稳定型心绞痛临床研究[J]. 新中医,2021, 53(21): 72-75.

[3] 程继侠,王西丽,张媛,等. 通脉降浊方加减对冠心病稳定性心绞痛患者血流动力学及血清IL-6、MCP-1水平的影响[J]. 四川中医,2021,39(8):66-69.

[4] 郑莹芊,彭廷云. 隔药饼灸干预阳虚水泛型冠心病心绞痛40例效果观察[J]. 湖南中医杂志,2021,37(4):98-100.

[5] 王俊力,李立为,田强强,等. 基于"双心疾病"理论探讨舒心口服液联合西医常规疗法治疗稳定性冠心病合并焦虑的临床疗效[J]. 上海中医药大学学报,2021, 35(5): 14-19.

[6] 《中成药治疗优势病种临床应用指南》标准化项目组. 中成药治疗冠心病临床应用指南(2020年)[J]. 中国中西医结合杂志,2021,41(4):391-417.

[7] 王贤良,莫欣宇,王帅,等. 八段锦对稳定性冠心病患者运动心肺功能及生存质量影响的随机对照试验[J]. 中医杂志,2021,62(10):881-886,903.

[8] 胡晶,高双庆,王阶,等. 脑梗死与冠心病患者使用血栓心脉宁片的疾病负担及直接医疗费用分析[J]. 中国中药杂志,2021,46(9):2309-2316. 

[9] 张磊,李会芳,刘红梅,等. 通心颗粒治疗冠心病心绞痛(气虚血瘀证)临床观察[J]. 四川中医,2021,39(7):91-94.

[10] 杨俊国,郭会军. 化痰祛瘀通脉汤联合美托洛尔治疗冠心病心绞痛的疗效[J]. 深圳中西医结合杂志,2021, 31(13): 42-43.

引用本文

潘吉猛, 吕沛霖, 中西药联合治疗冠心病心绞痛临床观察[J]. 国际中医药研究, 2022; 2: (1) : 18-20.